GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Scaled Net Operating Assets

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Scaled Net Operating Assets : 0.84 (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Wanbangde Pharmaceutical Holding Group Co's operating assets for the quarter that ended in Sep. 2024 was ¥4,173 Mil. Wanbangde Pharmaceutical Holding Group Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥543 Mil. Wanbangde Pharmaceutical Holding Group Co's Total Assets for the quarter that ended in Jun. 2024 was ¥4,322 Mil. Therefore, Wanbangde Pharmaceutical Holding Group Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.84.


Wanbangde Pharmaceutical Holding Group Co Scaled Net Operating Assets Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Scaled Net Operating Assets Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 0.81 0.47 0.74 0.83

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.80 0.84 0.81 0.84

Competitive Comparison of Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets falls into.



Wanbangde Pharmaceutical Holding Group Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(4069.75-562.664)/4218.157
=0.83

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4296.358 - 226.608
=4069.75

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1537.385 - 93.494 - 881.227
=562.664

Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(4172.656-542.89)/4321.708
=0.84

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4268.452 - 95.796
=4172.656

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1504.947 - 94.64 - 867.417
=542.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbangde Pharmaceutical Holding Group Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines